SG Americas Securities, LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 134 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$118
-25.8%
22,295
-12.1%
0.00%
-50.0%
Q4 2022$159
-99.9%
25,369
+8.2%
0.00%
-33.3%
Q3 2022$247,000
+197.6%
23,440
+52.7%
0.00%
+200.0%
Q2 2022$83,000
-59.7%
15,347
+77.6%
0.00%0.0%
Q3 2021$206,0008,6400.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q4 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders